Does LENALIDOMIDE Cause Myelodysplastic syndrome? 1,285 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,285 reports of Myelodysplastic syndrome have been filed in association with LENALIDOMIDE (LENALIDOMIDE). This represents 0.4% of all adverse event reports for LENALIDOMIDE.
1,285
Reports of Myelodysplastic syndrome with LENALIDOMIDE
0.4%
of all LENALIDOMIDE reports
563
Deaths
238
Hospitalizations
How Dangerous Is Myelodysplastic syndrome From LENALIDOMIDE?
Of the 1,285 reports, 563 (43.8%) resulted in death, 238 (18.5%) required hospitalization, and 88 (6.8%) were considered life-threatening.
Is Myelodysplastic syndrome Listed in the Official Label?
Yes, Myelodysplastic syndrome is listed as a known adverse reaction in the official FDA drug label for LENALIDOMIDE.
What Other Side Effects Does LENALIDOMIDE Cause?
Diarrhoea (27,576)
Fatigue (22,956)
Death (19,213)
Off label use (17,017)
Rash (15,794)
Pneumonia (14,807)
Plasma cell myeloma (14,191)
Neuropathy peripheral (10,215)
White blood cell count decreased (9,996)
Constipation (9,635)
What Other Drugs Cause Myelodysplastic syndrome?
CYCLOPHOSPHAMIDE (1,545)
DOXORUBICIN (1,236)
RITUXIMAB (1,054)
VINCRISTINE (966)
ETOPOSIDE (936)
DEXAMETHASONE (759)
METHOTREXATE (728)
CYTARABINE (715)
CARBOPLATIN (698)
PREDNISONE (661)
Which LENALIDOMIDE Alternatives Have Lower Myelodysplastic syndrome Risk?
LENALIDOMIDE vs LENIOLISIB
LENALIDOMIDE vs LENOGRASTIM
LENALIDOMIDE vs LENVATINIB
LENALIDOMIDE vs LEPONEX
LENALIDOMIDE vs LERCANIDIPINE